Randomly selected IDH-wildtype grade II-III astrocytoma have statistically identical prognoses compared to IDH-wildtype glioblastoma [36,43,52], and many tumors originally diagnosed as IDH-wildtype lower-grade astrocytomas can now be separated into other diagnostic categories [124,125]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).